ClassID:

21256

A61K45/06 - page 12 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#3301
20250017947
2025-01-16

COMBINATION

#3302
20250017941
2025-01-16

METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE

#3303
20250017939
2025-01-16

Antiviral Therapy

#3304
20250017933
2025-01-16

CANCER TREATMENT USING LSD1 INHIBITORS AND PLK1 INHIBITORS

#3305
20250017925
2025-01-16

MODULATORS OF KV3 CHANNELS TO TREAT PAIN

#3306
20250017899
2025-01-16

METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDACI) SUBSTANCES

#3307
20250017883
2025-01-16

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

#3308
20250017878
2025-01-16

USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY

#3309
20250017875
2025-01-16

STABLE CANNABINOID FORMULATIONS

#3310
20250017874
2025-01-16

PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION

#3311
20250017873
2025-01-16

TOPICAL PEEL-OFF CREAM FOR NUMBING PAIN DURING SKIN-RELATED PROCEDURES

#3312
20250017864
2025-01-16

COMPOSITIONS FOR CELL-BASED THERAPIES AND RELATED METHODS

#3313
20250017860
2025-01-16

Membrane Encapsulated Nanoparticles and Method of Use

#3314
20250017856
2025-01-16

CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS

#3315
20250017855
2025-01-16

Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin

#3316
20250012798
2025-01-09

METHODS FOR DEFINING STAGES AND PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS

#3317
20250011794
2025-01-09

TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME

#3318
20250011789
2025-01-09

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

#3319
20250011721
2025-01-09

COMPOSITIONS AND METHODS FOR IMPLANTATION OF PROCESSED ADIPOSE TISSUE AND PROCESSED ADIPOSE TISSUE PRODUCTS

#3320
20250011472
2025-01-09

DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP)

#3321
20250011466
2025-01-09

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

#3322
20250011458
2025-01-09

Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies

#3323
20250011456
2025-01-09

ANTIBODIES AGAINST CD14 AND USES THEREOF

#3324
20250011445
2025-01-09

COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS

#3325
20250011442
2025-01-09

ANTI-IL36R ANTIBODIES

#3326
20250011438
2025-01-09

Antibody Binding to Tie2 and Use Thereof

#3327
20250011436
2025-01-09

CLEC12a Binding Polypeptides and Uses Thereof

#3328
20250011415
2025-01-09

Safe and Effective Method of Treating Lupus with Anti-IL/IL23 Antibody

#3329
20250011404
2025-01-09

TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY

#3330
20250011402
2025-01-09

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

#3331
20250011389
2025-01-09

IMMUNE CELLS DEFECTIVE FOR SUV39H1

#3332
20250011380
2025-01-09

METHODS OF TREATING AGING-RELATED DISORDERS

#3333
20250011377
2025-01-09

SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES

#3334
20250011370
2025-01-09

THERAPEUTIC TREATMENT

#3335
20250011352
2025-01-09

SOLID FORMS

#3336
20250011351
2025-01-09

PSILOCYBIN AND O-ACETYLPSILOCIN, SALTS AND SOLID STATE FORMS THEREOF

#3337
20250011326
2025-01-09

FUSED HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF HBV INFECTION

#3338
20250011325
2025-01-09

IRAK DEGRADERS AND USES THEREOF

#3339
20250011318
2025-01-09

CBL-B INHIBITORS AND METHODS OF USE THEREOF

#3340
20250011308
2025-01-09

CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF

#3341
20250011304
2025-01-09

CRYSTALLINE FORM OF N-(2-CHLORO-3-((5-CHLORO-3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)AMINO)-4-FLUOROPHENYL)-3-FLUOROAZETIDINE-1-SULFONAMIDE

#3342
20250011285
2025-01-09

CYP11A1 INHIBITORS

#3343
20250009918
2025-01-09

NANOPARTICLES FOR POTENTIATING EFFECTS OF RADIATION THERAPY ON ANTI-CANCER IMMUNOTHERAPY

#3344
20250009916
2025-01-09

COMBINATION THERAPY FOR TREATING LUNG CANCER

#3345
20250009912
2025-01-09

COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES

#3346
20250009900
2025-01-09

OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE

#3347
20250009894
2025-01-09

DENDRIMER COMPOSITIONS AND METHODS FOR TREATMENT OF SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME

#3348
20250009891
2025-01-09

CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS

#3349
20250009861
2025-01-09

ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF

#3350
20250009856
2025-01-09

METHODS FOR TREATING RESPIRATORY DISEASES

#3351
20250009851
2025-01-09

SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS

#3352
20250009844
2025-01-09

MATURATION OF MUCOSAL DEFENSE AND GUT/LUNG FUNCTION IN THE PRETERM INFANT

#3353
20250009836
2025-01-09

COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY

#3354
20250009832
2025-01-09

COMPOSITION FOR INHIBITING PROLIFERATION OF TUMOR COMPRISING SANGUISORBA OFFICINALIS EXTRACT AS EFFECTIVE COMPONENT

#3355
20250009831
2025-01-09

COMBINATION OF SCUTELLARIA EXTRACTS WITH CITRUS BERGAMIA OR CYNARA CARDUNCULUS EXTRACTS AND FORMULATIONS CONTAINING THEM

#3356
20250009814
2025-01-09

METHODS AND COMPOSITIONS FOR TREATING MUSCULOSKELETAL DISEASES

#3357
20250009782
2025-01-09

BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT

#3358
20250009781
2025-01-09

Methods and Compositions for Treating Cancers and Enhancing Therapeutic Immunity by Selectively Reducing Immunomodulatory M2 Monocytes

#3359
20250009780
2025-01-09

AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-POSITIVE CANCERS

#3360
20250009778
2025-01-09

KRAS ANTAGONISTS

#3361
20250009773
2025-01-09

COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6

#3362
20250009772
2025-01-09

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#3363
20250009767
2025-01-09

Adhesive Oral Disc For Sustained Release Of Cannabinoids

#3364
20250009763
2025-01-09

METHODS FOR EXTENDING LIFESPAN AND/OR DELAYING AGING

#3365
20250009755
2025-01-09

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES AND INJURIES

#3366
20250009753
2025-01-09

METHODS FOR TREATING IMMUNE REFRACTORY LUNG CANCER

#3367
20250009743
2025-01-09

METHODS OF TREATING CANCERS USING STING AGONISTS

#3368
20250009737
2025-01-09

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#3369
20250009733
2025-01-09

ORAL PRODUCT

#3370
20250009730
2025-01-09

IFENPRODIL SALTS AND THERAPEUTIC USES THEREOF

#3371
20250009727
2025-01-09

WATER-SOLUBLE SALTS OF DNA BINDING AGENTS

#3372
20250009723
2025-01-09

MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE

#3373
20250009715
2025-01-09

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

#3374
20250009711
2025-01-09

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

#3375
20250009710
2025-01-09

COMPOSITION CONTAINING ARTESUNATE

#3376
20250009700
2025-01-09

METHODS AND COMPOSITIONS FOR TREATING INFECTION AND INFLAMMATION WITH SELENOCYANATE

#3377
20250009696
2025-01-09

METHODS OF CANCER TREATMENT VIA REGULATED FERROPTOSIS

#3378
20250009691
2025-01-09

DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER

#3379
20250009688
2025-01-09

NEUTROPHIL SUPPRESSION AS PRECONDITIONING TO INCREASE ONCOLYTIC BACTERIAL THERAPY

#3380
20250009679
2025-01-09

CATIONIC LIPID-BASED NANOCARRIER AND PREPARATION METHOD AND APPLICATION THEREOF

#3381
20250009663
2025-01-09

Mouthwash For Oral Care Benefits

#3382
20250009657
2025-01-09

LIPID EMULSIONS FOR PARENTERAL NUTRITION

#3383
20250002918
2025-01-02

COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS

#3384
20250002866
2025-01-02

CELL CULTURE PLATFORMS, METHODS AND USES THEREOF

#3385
20250002591
2025-01-02

INHIBITOR OF TYPE 1 INTERFERON RECEPTOR STEROID SPARING IN SYSTEMIC LUPUS ERYTHERMATOSUS PATIENTS

#3386
20250002571
2025-01-02

Camelid/Llama Nanobodies to Target WNT16B as a Chemotherapy Option for Cancer Treatment

#3387
20250002554
2025-01-02

DELTA PROTOCADHERIN THERAPIES

#3388
20250002513
2025-01-02

ANTIVIRAL COMPOUNDS

#3389
20250002497
2025-01-02

IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION

#3390
20250002486
2025-01-02

CYCLIC SULFONAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

#3391
20250002451
2025-01-02

Lipid compound containing carbamate bond and applications thereof

#3392
20250002448
2025-01-02

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#3393
20250001166
2025-01-02

COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS

#3394
20250001015
2025-01-02

AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY IN GLAUCOMA

#3395
20250001010
2025-01-02

NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER

#3396
20250000991
2025-01-02

NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#3397
20250000990
2025-01-02

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

#3398
20250000942
2025-01-02

PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION

#3399
20250000936
2025-01-02

TREATMENT OF GEOGRAPHIC ATROPHY

#3400
20250000933
2025-01-02

TERLIPRESSIN COMPOSITIONS AND THEIR METHODS OF USE

#3401
20250000924
2025-01-02

Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient

#3402
20250000923
2025-01-02

Use of extracellular vesicles of Rhizoma Drynariae in preparation of medicine for treating orthopedic diseases

#3403
20250000915
2025-01-02

METHODS OF POPULATING A GASTROINTESTINAL TRACT

#3404
20250000895
2025-01-02

POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S)

#3405
20250000889
2025-01-02

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

#3406
20250000878
2025-01-02

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

#3407
20250000861
2025-01-02

METHODS OF TREATING OCULAR CONDITIONS

#3408
20250000856
2025-01-02

CRYSTALLINE FORMS OF N-((1R,3S)-3-(4-ACETYLPIPERAZIN-1-YL)CYCLOHEXYL)-4-FLUORO-7-METHYL-1H-INDOLE-2-CARBOXAMIDE

#3409
20250000853
2025-01-02

COMBINATION OF A PD-1 ANTAGONIST AND A VEGF-R/FGFR/RET TYROSINE KINASE INHIBITOR FOR TREATING CANCER

#3410
20250000833
2025-01-02

Fatty acid compositions

#3411
20250000830
2025-01-02

DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF

#3412
20250000818
2025-01-02

NEW SYNERGISTIC COMBINATIONS BASED ON FENM AND AN ACETYLCHOLINESTERASE INHIBITOR

#3413
20250000817
2025-01-02

Methods of Treating Mitochondrial Dysfunction

#3414
20250000813
2025-01-02

OROMUCOSAL NANOFIBER CARRIERS FOR THERAPEUTIC TREATMENT

#3415
20250000798
2025-01-02

METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES

#3416
20250000384
2025-01-02

METHODS FOR MAGNETIC RESONANCE IMAGING OF NANOCONSTRUCTS AND USES THEREOF

#3417
20250000364
2025-01-02

GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS

#3418
20240426840
2024-12-26

COMPOSITIONS AND METHODS FOR DETECTING AND TREATMENT OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

#3419
20240425934
2024-12-26

METHODS OF SELECTING AND TREATING CANCER SUBJECTS THAT ARE CANDIDATES FOR TREATMENT USING INHIBITORS OF PARP

#3420
20240425859
2024-12-26

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

#3421
20240425611
2024-12-26

Trispecific T cell Engagers

#3422
20240425602
2024-12-26

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH

#3423
20240425601
2024-12-26

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH AVB8 INTEGRIN

#3424
20240425593
2024-12-26

ANTI-PD-1 ANTIBODY AND USE THEREOF

#3425
20240425589
2024-12-26

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT FOR USE IN TREATMENT OF CANCER

#3426
20240425585
2024-12-26

ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

#3427
20240425582
2024-12-26

METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

#3428
20240425580
2024-12-26

Anti-IL-33 Antibodies and Uses Thereof

#3429
20240425579
2024-12-26

COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING

#3430
20240425569
2024-12-26

ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF

#3431
20240425558
2024-12-26

PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#3432
20240425542
2024-12-26

CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS

#3433
20240425520
2024-12-26

BCL-2 INHIBITORS

#3434
20240425516
2024-12-26

SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF

#3435
20240425514
2024-12-26

ALSTONINE DERIVATIVES AND SALTS THEREOF

#3436
20240425509
2024-12-26

NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF

#3437
20240425497
2024-12-26

Cbl-b Inhibitors and Methods of Use Thereof

#3438
20240425490
2024-12-26

SULFAMIDE RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

#3439
20240425453
2024-12-26

ISOINDOLINES AS PMS2 INHIBITORS

#3440
20240425452
2024-12-26

ISOLATED TRANS ISOMER OF 3-(2-BROMO-3,4-DIHYDROXY-PHENYL)-N-(3,4,5-TRIHYDROXY-BENZYL)-THIOACRYLAMIDE

#3441
20240425443
2024-12-26

Methods for making and using endoxifen

#3442
20240424268
2024-12-26

SWALLOWABLE DRUG DELIVERY DEVICE AND METHODS OF DRUG DELIVERY

#3443
20240424153
2024-12-26

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

#3444
20240424133
2024-12-26

mRNA THERAPY WITH REDUCED IMMUNE REACTOGENICITY

#3445
20240424045
2024-12-26

BERBERIS COMPOSITION FOR COGNITIVE HEALTH

#3446
20240424042
2024-12-26

PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE PREVENTION OR TREATMENT OF VIRAL INFECTIONS

#3447
20240424031
2024-12-26

COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY

#3448
20240424024
2024-12-26

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

#3449
20240424019
2024-12-26

SHP1 MODIFIED DENDRITIC CELLS AND EXTRACELLULAR VESICLES DERIVED THEREFROM AND ASSOCIATED METHODS

#3450
20240424016
2024-12-26

BUFFERING FOR NON-ALCOHOLIC STEATOHEPATITIS AND LIVER DISEASES

#3451
20240424009
2024-12-26

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

#3452
20240423996
2024-12-26

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

#3453
20240423995
2024-12-26

C-KIT INHIBITORS AND USES FOR TREATING AND PREVENTING INFLAMMATORY CONDITIONS

#3454
20240423988
2024-12-26

Improvement of Tumor Immunogenicity by Means of Splicing-Controlling Compound

#3455
20240423982
2024-12-26

TREATMENT OR PREVENTION OF NEW-ONSET TYPE 1 DIABETES WITH BARICITINIB

#3456
20240423980
2024-12-26

METHODS OF PREVENTING A VENOUS THROMBOEMBOLIC EVENT

#3457
20240423975
2024-12-26

TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA

#3458
20240423974
2024-12-26

Tamper Resistant Immediate Release Formulations

#3459
20240423966
2024-12-26

SULFASALAZINE SALTS, PRODUCTION PROCESSES AND USES

#3460
20240423934
2024-12-26

COMPOSITIONS IN THE FORM OF A UREA POWDER

#3461
20240423931
2024-12-26

STABLE AQUEOUS CAPSAICIN INJECTABLE FORMULATIONS AND MEDICAL USES THEREOF

#3462
20240423929
2024-12-26

EFFECT OF GLYCEROL ON BIOFILM FORMING BACTERIA AND FUNGI THAT CHANGES THE MICROBES SENSITIVITY TO PRO AND ANTI-BIOFILM NON-TOXIC, NON-BONDED PLASMA AMINO ACIDS AND AMINO ACID DERIVATIVES

#3463
20240423923
2024-12-26

EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON ADMINISTRATION, AND USES

#3464
20240423917
2024-12-26

USE OF NANOPARTICLES FOR THE TREATMENT OF FISTULIZING ANOPERINEAL LESIONS

#3465
20240423913
2024-12-26

TREATMENT USING THERMOSENSITIVE LIPOSOMES

#3466
20240423908
2024-12-26

Improved Nasal Administration of Parkinson's Therapeutics

#3467
20240417751
2024-12-19

RNA REPLICON FOR IMPROVING GENE EXPRESSION AND USE THEREOF

#3468
20240417722
2024-12-19

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

#3469
20240417483
2024-12-19

MONOCLONAL ANTIBODY AND A METHOD THEREOF

#3470
20240417421
2024-12-19

NMN And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of Parkinsonism

#3471
20240417411
2024-12-19

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

#3472
20240417408
2024-12-19

SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT

#3473
20240417404
2024-12-19

CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION

#3474
20240417398
2024-12-19

TETRAHYDRONAPTHYRIDINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

#3475
20240417378
2024-12-19

G-PROTEIN-COUPLED RECEPTOR REGULATORS AND METHODS OF USE THEREOF

#3476
20240417377
2024-12-19

COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA

#3477
20240417363
2024-12-19

Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease

#3478
20240416127
2024-12-19

MODULATION OF NEURONAL NKCC1 AS A THERAPEUTIC STRATEGY FOR SPASTICITY AND RELATED DISORDERS

#3479
20240415982
2024-12-19

GENE THERAPY WITH THE GENES HOKD AND LDRB FOR CANCER TREATMENT

#3480
20240415959
2024-12-19

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

#3481
20240415956
2024-12-19

COMPOSITIONS AND METHODS FOR ENHANCING EFFICACY AND REDUCING ADVERSE EFFECTS FROM COVID VACCINATION

#3482
20240415912
2024-12-19

COMPOSITIONS AND METHODS FOR IMMUNE HEALTH

#3483
20240415897
2024-12-19

USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

#3484
20240415896
2024-12-19

ANTIMICROBIAL COMPOSITIONS

#3485
20240415894
2024-12-19

MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA

#3486
20240415884
2024-12-19

MOLECULES THAT BIND TO CD276 POLYPEPTIDES

#3487
20240415872
2024-12-19

OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME

#3488
20240415871
2024-12-19

METHODS FOR TREATING ALZHEIMER’S DISEASE

#3489
20240415847
2024-12-19

BETA-LACTAMASE INHIBITORS AND USES THEREOF

#3490
20240415845
2024-12-19

Compositions of Iboga Alkaloids and Methods of Treatment

#3491
20240415844
2024-12-19

Methods of Treatment With an Iboga Alkaloid

#3492
20240415841
2024-12-19

SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY

#3493
20240415838
2024-12-19

USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION

#3494
20240415836
2024-12-19

COMPOSITION COMPRISING TWO ENZYME INHIBITORS TARGETING TWO DIFFERENT CONFORMATIONS OF AN ENZYME

#3495
20240415830
2024-12-19

COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY

#3496
20240415827
2024-12-19

NICOTINE LOZENGE

#3497
20240415824
2024-12-19

USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR

#3498
20240415823
2024-12-19

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND LOSARTAN

#3499
20240415822
2024-12-19

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CALCIUM CHANNEL BLOCKERS

#3500
20240415821
2024-12-19

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-FIBROTIC AGENTS THAT ARE NON-TUMORIGENIC

#3501
20240415818
2024-12-19

COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS

#3502
20240415817
2024-12-19

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

#3503
20240415812
2024-12-19

Psychoactive alkaloid extraction and composition with inhibited dephosphorylation

#3504
20240415809
2024-12-19

PHARMACEUTICAL COMBINATIONS

#3505
20240415806
2024-12-19

METHODS OF TREATING PRADER-WILLI SYNDROME

#3506
20240415805
2024-12-19

COMPOSITIONS AND METHODS OF TREATING INVASIVE PATHOGENS

#3507
20240415799
2024-12-19

COMPOSITION FOR LIVING BODY

#3508
20240415791
2024-12-19

Therapeutic methods and compositions for treating cancer using devimistat and a fatty acid oxidation inhibitor, a tyrosine kinase inhibitor, a glutaminase inhibitor, and/or a glycolysis inhibitor

#3509
20240415789
2024-12-19

CYCLOBENZAPRINE FOR TREATMENT OR PREVENTION OF SEXUAL DYSFUNCTION ASSOCIATED WITH MENTAL HEALTH CONDITIONS IN FEMALE PATIENTS

#3510
20240415782
2024-12-19

Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof

#3511
20240415776
2024-12-19

A METHOD FOR PREPARING A VETERINARY MEDICAMENT DOSAGE WITH INKS AND A VETERINARY MEDICAMENT DOSAGE OBTAINABLE BY THE METHOD

#3512
20240415764
2024-12-19

Wound dressing

#3513
20240415678
2024-12-19

A Drug-Eluting Stent Comprising a Biocompatible Thermoplastic Polymer Lining and a Drug- Containing Coating

#3514
20240415433
2024-12-19

SYSTEMS AND METHODS FOR DETECTING ANXIETY USING EEG

#3515
20240410902
2024-12-12

USE OF SOLUBLE TREM2 AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#3516
20240409934
2024-12-12

FOXO1-TARGETED THERAPY FOR THE TREATMENT OF CANCER

#3517
20240409930
2024-12-12

MUC5B-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION

#3518
20240409892
2024-12-12

METHOD OF DIRECTED DIFFERENTIATION PRODUCING CORNEAL ENDOTHELIAL CELLS, COMPOSITIONS THEREOF, AND USES THEREOF

#3519
20240409668
2024-12-12

MONOVALENT ASYMMETRIC TANDEM FAB BISPECIFIC ANTIBODIES

#3520
20240409661
2024-12-12

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

#3521
20240409647
2024-12-12

BISPECIFIC BINDING PROTEINS AGAINST ALARMINS AND USES THEREOF

#3522
20240409637
2024-12-12

ANTI-CD8 ANTIBODIES AND USES THEREOF

#3523
20240409627
2024-12-12

INHIBIN ANTIBODIES AND CANCER TREATMENT

#3524
20240409619
2024-12-12

ANTIBODIES FOR USE AGAINST SARS-COV-2

#3525
20240409576
2024-12-12

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

#3526
20240409573
2024-12-12

CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF

#3527
20240409556
2024-12-12

BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

#3528
20240409545
2024-12-12

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

#3529
20240409542
2024-12-12

NOVEL COMPOUNDS

#3530
20240409541
2024-12-12

NK3 modulators and uses thereof

#3531
20240409538
2024-12-12

SUBSTITUTED TRIAZOLOHETEROARYL COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOF

#3532
20240409531
2024-12-12

BENZOXAZINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

#3533
20240409529
2024-12-12

Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the Same

#3534
20240409526
2024-12-12

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

#3535
20240409514
2024-12-12

METHODS FOR INHIBITING NATIVE AND PROMISCUOUS UPTAKE OF MONOAMINE NEUROTRANSMITTERS

#3536
20240409513
2024-12-12

CRYSTALLINE TRYPTAMINE COMPOUNDS

#3537
20240408387
2024-12-12

COMBINATION ELECTRICAL THERAPY WITH OTHER CANCER THERAPIES

#3538
20240408240
2024-12-12

TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS

#3539
20240408237
2024-12-12

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING A CARTILAGE DAMAGE USING SOX9 GENE

#3540
20240408206
2024-12-12

COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES

#3541
20240408186
2024-12-12

TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH TOLERIZING NANOPARTICLES

#3542
20240408153
2024-12-12

BACTERIA USEFUL IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES

#3543
20240408150
2024-12-12

ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1, ANTI-PD-L1 OR ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF CANCER

#3544
20240408149
2024-12-12

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM

#3545
20240408131
2024-12-12

ISOTONIC OR HYPERTONIC SALT-BASED COMPOSITIONS

#3546
20240408120
2024-12-12

METHODS FOR INCREASING FAT ABSORPTION

#3547
20240408117
2024-12-12

COMPOSITIONS AND METHODS FOR TREATING HEMIPLEGIC MIGRAINE

#3548
20240408112
2024-12-12

METHOD FOR PREVENTING OR TREATING PULMONARY ARTERIAL HYPERTENSION BY USING 7-DEHYDROCHOLESTEROLS OR SALTS, OXIDES, METABOLITES, OR DERIVATIVES THEREOF

#3549
20240408104
2024-12-12

COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION

#3550
20240408092
2024-12-12

PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES

#3551
20240408086
2024-12-12

USE OF LUVADAXISTAT FOR THE TREATMENT OF COGNITIVE IMPAIRMENT

#3552
20240408068
2024-12-12

Helicase Primase Inhibitors For Treating Cancer In A Combination Therapy With Oncolytic Viruses

#3553
20240408057
2024-12-12

Composition for preventing or treating cachexia and muscle loss

#3554
20240408050
2024-12-12

DIHYDROMYRICETIN SPRAY-DRIED DISPERSION FORMULATIONS AND METHODS FOR FORMING THEM

#3555
20240408046
2024-12-12

CANNABINOID PRODRUG COMPOUNDS

#3556
20240408038
2024-12-12

SUBSTITUTED PHENYLALKYLAMINES

#3557
20240408025
2024-12-12

A FILM-FORMING COMPOSITION COMPRISING PECTIN

#3558
20240408024
2024-12-12

TAMPER RESISTANT DOSAGE FORMS

#3559
20240408023
2024-12-12

DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES

#3560
20240408012
2024-12-12

LIPOSOMAL COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE

#3561
20240408003
2024-12-12

COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDER

#3562
20240401075
2024-12-05

VECTOR FOR CANCER TREATMENT

#3563
20240401044
2024-12-05

EXPLOITING IL33 SECRETION AS A THERAPEUTIC TARGET IN CANCER

#3564
20240400721
2024-12-05

USES OF DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES

#3565
20240400714
2024-12-05

METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS

#3566
20240400698
2024-12-05

ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

#3567
20240400694
2024-12-05

METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES

#3568
20240400683
2024-12-05

MULTIFUNCTIONAL ANTIBODY-LIGAND TRAPS TO COUNTERACT IMMUNE TOLERANCE

#3569
20240400678
2024-12-05

ANTIBODIES FOR SIGLEC-15 AND METHODS OF USE THEREOF TO TREAT DISUSE OSTEOPOROSIS

#3570
20240400674
2024-12-05

CLAUDIN 4 AND CLAUDIN 9 ANTIBODIES AND METHODS OF TREATING CANCER

#3571
20240400666
2024-12-05

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

#3572
20240400664
2024-12-05

Anti-Sclerostin Antibodies and Their Use to Treat Bone Disorders as Part of a Regimen

#3573
20240400659
2024-12-05

CONDITIONALLY ACTIVE PROTEINS FOR NEURODEGENERATIVE DISEASES

#3574
20240400649
2024-12-05

MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE

#3575
20240400648
2024-12-05

POLYMERIC FORMS OF H-NOX PROTEINS

#3576
20240400646
2024-12-05

MEANS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS-, FIBROSIS- AND CANCER-RELATED DISEASES WITH PROTEIN OLIGOMERS COMPRISING NC-1-FC

#3577
20240400641
2024-12-05

Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer

#3578
20240400589
2024-12-05

4-AMINOPHENYLPHOSPHORYLCHOLINE COMPOUNDS FOR BLOCKING C-REACTIVE PROTEIN

#3579
20240400568
2024-12-05

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

#3580
20240400555
2024-12-05

Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors

#3581
20240400526
2024-12-05

SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE

#3582
20240400525
2024-12-05

1,2,4-Oxadiazole Derivatives as Immunomodulators

#3583
20240399127
2024-12-05

Vaginal Drug Delivery Device

#3584
20240398979
2024-12-05

Compositions and Methods for Treating Dopamine Disorders

#3585
20240398978
2024-12-05

Compositions and Methods for Treating Dopamine Disorders

#3586
20240398955
2024-12-05

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

#3587
20240398954
2024-12-05

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

#3588
20240398942
2024-12-05

USE OF ANTI-CD40 ANTIBODY

#3589
20240398914
2024-12-05

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR

#3590
20240398913
2024-12-05

METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

#3591
20240398909
2024-12-05

SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS

#3592
20240398906
2024-12-05

PROPEPTIDE OF LYSYL OXIDASE FOR TREATMENT OF CANCER

#3593
20240398904
2024-12-05

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#3594
20240398898
2024-12-05

COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS

#3595
20240398865
2024-12-05

TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF

#3596
20240398858
2024-12-05

PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF

#3597
20240398857
2024-12-05

COMPOSITIONS FOR MANAGEMENT OF HPV (HUMAN PAPILLOMA VIRUS) INFECTIONS

#3598
20240398852
2024-12-05

NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF INFLAMMATION-RELATED BURN INJURIES

#3599
20240398841
2024-12-05

BLADDER PERFUSION PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#3600
20240398831
2024-12-05

COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME